Is There a Difference Between CAR-T and TAFA-LEN?

The approval is targeting the third line setting. Many patients will have received CAR-T and it's quite encouraging to see that these drug are efficient in patients that feel CAR-T. I showed the data of EP-CoA, but this is a similar data for Gloffet. There is no possibility to differentiate these two drugs in time of efficacy and safety at this time.